Literature DB >> 6705006

Anaerobic glycolysis and the development of ischaemic contracture in isolated rat heart.

J A Lipasti, T J Nevalainen, K A Alanen, M A Tolvanen.   

Abstract

The relationship between myocardial ATP content and the increase in left ventricular resting tension during ischaemia (ischaemic contracture) was studied in isolated rat hearts perfused for 15 min either with aerobic buffer (pO2 greater than 500 mmHg) containing non-glycolytic substrate, acetate (5 mmol X litre-1), or with hypoxic buffer (pO2 less than 10 mmHg) with glucose (10 mmol X litre-1) before making them totally ischaemic for 10 min. ATP was determined spectrophotometrically from extracts of frozen whole hearts. Left ventricular tension was recorded by intraventricular balloon catheter. Myocardial ATP content was 15.4 +/- 1.0 mumol X g-1 dry weight (mumol X g-1) after 10 min stabilising period, 14.1 +/- 0.9 mumol X g-1 after 15 min aerobic perfusion (plus acetate) and 9.0 +/- 1.3 mumol X g-1 after 15 min hypoxic perfusion (plus glucose). During 10 min of ischaemia ATP decreased in aerobic hearts to 5.4 +/- 1.1 mumol X g-1 and to 7.9 +/- 1.0 mumol X g-1 in hypoxic hearts. The left ventricular resting tension increased during ischaemia in hypoxic hearts to 9 +/- 5% of control systolic pressure (0 = diastolic pressure, 100 = systolic pressure during stabilising period), whereas in aerobic hearts the tension began to increase immediately and was 84 +/- 22% of systolic pressure at the end of the ischaemic period. In parallel control experiments, hearts were also perfused either with glucose-containing aerobic buffer or acetate-containing hypoxic buffer. ATP was well preserved during aerobic perfusion (plus glucose) but decreased markedly during hypoxic perfusion (plus acetate). There was no increase in resting tension in the aerobic hearts (plus glucose) whereas the resting tension increased considerably during hypoxic perfusion (plus acetate). The results indicate that the initiation of ischaemic contracture occurs at much higher myocardial ATP level when ATP comes from mitochondrial sources than when ATP is generated by anaerobic glycolysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705006     DOI: 10.1093/cvr/18.3.145

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

1.  Hypoxia and glucose independently regulate the beta-adrenergic receptor-adenylate cyclase system in cardiac myocytes.

Authors:  K J Rocha-Singh; N Y Honbo; J S Karliner
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 2.  Myocardial ischemia--metabolic pathways and implications of increased glycolysis.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  Relations between the energy state of the myocardium and release of some products of anaerobic metabolism during underperfusion.

Authors:  O I Pisarenko; I M Studneva; V S Shulzhenko; V I Kapelko
Journal:  Pflugers Arch       Date:  1990-06       Impact factor: 3.657

Review 4.  Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte.

Authors:  L M King; L H Opie
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

5.  The effect of regular physical exercise on sensitivity to ischaemia in the rat's heart.

Authors:  P Kŏrge; G Männik
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

6.  Cardiac ischemia. Part I--Metabolic and physiologic responses.

Authors:  G A Langer; J N Weiss; H R Schelbert
Journal:  West J Med       Date:  1987-06

Review 7.  Oxidative substrate metabolism during postischemic reperfusion.

Authors:  R Lerch
Journal:  Basic Res Cardiol       Date:  1993 Nov-Dec       Impact factor: 17.165

8.  Increased left ventricular stiffness impairs filling in dogs with pulmonary emphysema in respiratory failure.

Authors:  A Gomez; S Mink
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.